scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2006.04.069 |
P8608 | Fatcat ID | release_y3lbaufei5e7rmqd7t3b4yiwjm |
P698 | PubMed publication ID | 16814434 |
P5875 | ResearchGate publication ID | 6971193 |
P2093 | author name string | Thierry Fontaine | |
Inge Holm | |||
Sarah Bonnet | |||
Stéphane Pêtres | |||
Shirley Longacre | |||
Sandrine Rosario | |||
Charles Roth | |||
P433 | issue | 33-34 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
Plasmodium falciparum | Q311383 | ||
malaria vaccine | Q6741353 | ||
P304 | page(s) | 5997-6008 | |
P577 | publication date | 2006-06-05 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate | |
P478 | volume | 24 |